findmyKOL

Anthony Demaria, MD

Enriched profile

Judith and Jack White Chair in Cardiology; Professor of Medicine; Founding Director, Sulpizio Cardiovascular Center · University of California, San Diego

ORCIDNPI
Region🇺🇸 San Diego, CA · West · United StatesSpecialtyCardiovascular DiseaseFocusHeart Failure
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceverified 2026Payments2021–2023NIH funding2014–2014

Anthony Demaria is Judith and Jack White Chair in Cardiology; Professor of Medicine; Founding Director, Sulpizio Cardiovascular Center at University of California, San Diego. OpenAlex indexes 780 publications with 38,059 citations (h-index 85); ClinicalTrials.gov lists 1 registered study with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Anthony N. DeMaria, MD, is Judith and Jack White Chair in Cardiology at University of California, San Diego. The public record shows 780 publications with 38,059 citations (h-index 85), centered on Heart Failure. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 4 companies, 1 NIH-funded awards (2014–2014).

  • Most recent indexed publication: 2024 · Journal of the American Heart Association
  • Top research focus: Heart Failure
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 4 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Failure1 trialHeart Failure, Diastolic1 trial

Research focus

OpenAlex concept fingerprint
Heart Failure

Drugs & molecules

across trials, industry payments and publications
Eliquisgeneric · ApixabanClinical trialsIndustry payments2PublicationsRimegepantClinical trialsIndustry payments2PublicationsNirmatrelvirClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Clinical trialsIndustry payments3JenaValve Technology, Inc.Clinical trialsIndustry payments2Pfizer Inc.Clinical trialsIndustry payments2

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
780publications

Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.

38,059citations

Total citations across indexed works.

85h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
4companies · 2021–2023

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 2014–2014

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

4 companies reported payments to CMS in program years 2021–2023. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    84.1%
    Statin23.7%
    Atorvastatin Calcium69%Rosuvastatin Calcium25%Simvastatin6%
    Part D<11 patients
    Beta blocker15.1%
    Metoprolol Succinate35%Carvedilol24%Metoprolol Tartrate22%Sotalol20%
    Part D26 patients
  • Blood & clotting

    13.5%
    Factor Xa inhibitor9.9%
    Eliquis86%Xarelto15%
    Part D<11 patients
    P2Y12 inhibitor3.7%
    Clopidogrel100%
    Part D13 patients
  • Metabolism & gastrointestinal

    2.3%
    SGLT2 inhibitor1.4%
    Jardiance100%
    Part D<11 patients
    GLP-1 receptor agonist0.9%
    Trulicity100%
    Part D<11 patients
Where care is delivered (Part B)93.8% facility · 6.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

1 NIH research award on record, funded 20142014 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/anthony-demaria-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • Other

    profiles.ucsd.edu/anthony.demaria

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsd.edu

Mentions by others

where others cite or feature them
  • Other

    acc.org/latest-in-cardiology/articles/2019/12/17/08/40/accel-lite-2019dec-p2

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acc.org
  • Other

    ucsd.tv/shows/Cardiac-Stem-Cells-Anthony-DeMaria-Deepak-Srivistava-Mark-Mercola-Deborah-Lieu-Pat-Farrant-36336

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ucsd.tv
  • ResearchGate

    ResearchGate profile: Anthony DeMaria, Professor, University of California San Diego, Department of Medicine

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net
1 more mention behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Subspecialty Board Certification

    Cardiovascular Disease

    1974
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →iscvdp.org
  • Diplomat

    American Board of Internal Medicine

    1972
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →iscvdp.org
  • M.D.

    New Jersey College of Medicine

    1968
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iscvdp.org
  • B.A.

    College of the Holy Cross

    1964
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iscvdp.org

Editorial & leadership roles

journal and society appointments
  • Editor-in-Chief

    Journal of the American College of Cardiology (JACC), January 2002–June 2014

    2014
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acc.org
  • Chairman

    Publications Committee, American Society of Echocardiography, 1993–present (as of CV)

    1993
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iscvdp.org
  • Board of Directors

    American Society of Echocardiography, 1975–present (as of CV)

    1975
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iscvdp.org
3 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record
7 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
  • Adjunct Professor

    Burnham Institute for Medical Research, San Diego, CA

    2008
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iscvdp.org
  • University of Kentucky College of Medicine

    Lexington, KY, Professor of Medicine and Chief, Cardiovascular Division, 1981–1992 (past)

    1992
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iscvdp.org

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.